Dr. Anish Thomas, MBBS, MD - National Cancer Institute

Dr. Anish Thomas

MBBS, MD

National Cancer Institute

Bethesda, MD | United States

Main Specialties: Oncology

Additional Specialties: Thoracic cancers

Dr. Anish Thomas, MBBS, MD - National Cancer Institute

Dr. Anish Thomas

MBBS, MD

Introduction

Primary Affiliation: National Cancer Institute - Bethesda, MD , United States

Specialties:

Additional Specialties:

Publications

32Publications

972Reads

75Profile Views

409PubMed Central Citations

Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directions.

J Thorac Oncol 2014 Nov;9(11):1609-17

*Thoracic and Gastrointestinal Oncology Branch, National Cancer Institute, Bethesda, Maryland; and †Department of Medicine, Division of Hematology/Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254270PMC
November 2014
44 Reads
13 Citations
5.282 Impact Factor

Immunotherapy for non-small-cell lung cancer.

Expert Opin Biol Ther 2014 Aug 30;14(8):1061-4. Epub 2014 May 30.

National Cancer Institute, National Institutes of Health, Center for Cancer Research, Thoracic and GI Oncology Branch , Building 10-CRC/4-5330, Bethesda, MD 20892 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2014.925874DOI Listing
August 2014
31 Reads
1 Citation
3.743 Impact Factor

Novel biologic therapies for thymic epithelial tumors.

Front Oncol 2014 7;4:103. Epub 2014 May 7.

Thoracic and Gastrointestinal Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019864PMC
May 2014
15 Reads
3 Citations

Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.

J Thorac Oncol 2014 Apr;9(4):567-71

*Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; †Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and ‡Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705182PMC
April 2014
66 Reads
4 Citations
5.282 Impact Factor

From platinum compounds to targeted therapies in advanced thoracic malignancies.

Anticancer Res 2014 Jan;34(1):477-82

Oregon Health and Sciences University 3181 SW Sam Jackson Park Rd, Portland, OR, U.S.A.

View Article

Download full-text PDF

Source
January 2014
18 Reads
1.872 Impact Factor

Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression.

Sci Transl Med 2013 Oct;5(208):208ra147

Laboratory of Molecular Biology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3006941DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369691PMC
October 2013
71 Reads
75 Citations
15.843 Impact Factor

Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy.

Front Oncol 2013 Oct 9;3:261. Epub 2013 Oct 9.

University of Zagreb, School of Medicine, Department for Respiratory Diseases Jordanovac, University Hospital Center Zagreb , Zagreb , Croatia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793201PMC
October 2013
21 Reads
12 Citations

Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.

Clin Lung Cancer 2013 Jul 26;14(4):452-6. Epub 2013 Mar 26.

Medical Oncology Branch, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2013.01.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002228PMC
July 2013
31 Reads
2 Citations
3.104 Impact Factor

New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.

Am J Pathol 2013 Apr 8;182(4):1065-77. Epub 2013 Feb 8.

Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont 05405-0068, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2012.12.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657618PMC
April 2013
32 Reads
28 Citations
4.591 Impact Factor

Farletuzumab in lung cancer.

Lung Cancer 2013 Apr 26;80(1):15-8. Epub 2013 Jan 26.

Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2012.12.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595339PMC
April 2013
19 Reads
8 Citations
3.960 Impact Factor

"Pseudocavitation" in thymic carcinoma during treatment with sunitinib.

J Thorac Oncol 2013 Apr;8(4):511-2

Medical Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318284378fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602913PMC
April 2013
40 Reads
1 Citation
5.282 Impact Factor

18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.

Clin Cancer Res 2013 Mar 4;19(6):1487-93. Epub 2013 Feb 4.

Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2929DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602145PMC
March 2013
30 Reads
3 Citations
8.722 Impact Factor

Characterization and management of cardiac involvement of thymic epithelial tumors.

J Thorac Oncol 2013 Feb;8(2):246-9

Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31827bd931DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552332PMC
February 2013
18 Reads
3 Citations
5.282 Impact Factor

Hepatoid carcinoma of the lung with anaplastic lymphoma kinase gene rearrangement.

J Thorac Oncol 2012 Nov;7(11):e29-31

Medical Oncology Branch Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182697a23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474982PMC
November 2012
34 Reads
1 Citation
5.282 Impact Factor

Response to crizotinib in ROS1-rearranged non-small-cell lung cancer.

J Clin Oncol 2012 Sep 13;30(27):3425-6; author reply 3426. Epub 2012 Aug 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.42.4556DOI Listing
September 2012
32 Reads
4 Citations
18.430 Impact Factor

Immunotherapies for non-small-cell lung cancer and mesothelioma.

Lancet Oncol 2012 Jul 28;13(7):e301-10. Epub 2012 Jun 28.

Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70126-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317076PMC
July 2012
9 Reads
33 Citations
24.690 Impact Factor

Tyrosine kinase inhibitors in lung cancer.

Hematol Oncol Clin North Am 2012 Jun 2;26(3):589-605, viii. Epub 2012 Mar 2.

Medical Oncology Branch, National Cancer Institution, Room 12N226, 10 Center Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2012.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334853PMC
June 2012
35 Reads
4 Citations
2.295 Impact Factor

Second malignancies after multiple myeloma: from 1960s to 2010s.

Blood 2012 Mar 6;119(12):2731-7. Epub 2012 Feb 6.

Multiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-12-381426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327452PMC
March 2012
4 Reads
30 Citations
10.452 Impact Factor

Myeloma and second primary cancers.

N Engl J Med 2011 Dec;365(23):2241-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1111010DOI Listing
December 2011
12 Reads
14 Citations
55.873 Impact Factor

Absence of mutation at the 5'-upstream promoter region of the TPM4 gene from cardiac mutant axolotl (Ambystoma mexicanum).

Cardiovasc Toxicol 2011 Sep;11(3):235-43

Department of Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12012-011-9117-zDOI Listing
September 2011
11 Reads
6 Citations
2.060 Impact Factor

Short communication: no evidence of HTLV-3 and HTLV-4 infection in New York State subjects at risk for retroviral infection.

AIDS Res Hum Retroviruses 2010 Nov 7;26(11):1229-31. Epub 2010 Oct 7.

Division of Hematology/Oncology, Department of Medicine, State University of New York , Upstate Medical University, Syracuse, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2010.0079DOI Listing
November 2010
16 Reads
3 Citations
2.330 Impact Factor

Expression of a novel tropomyosin isoform in axolotl heart and skeletal muscle.

J Cell Biochem 2010 Jul;110(4):875-81

Department of Medicine, SUNY Upstate Medical University, Syracuse, New York 13210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.22599DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895019PMC
July 2010
23 Reads
9 Citations
3.263 Impact Factor

Isolated CNS relapse of CML after bone marrow transplantation.

Leuk Res 2010 Apr 6;34(4):e113-4. Epub 2009 Oct 6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2009.09.022DOI Listing
April 2010
7 Reads
5 Citations
2.351 Impact Factor

LGL leukemia and HTLV.

AIDS Res Hum Retroviruses 2010 Jan;26(1):33-40

Department of Medicine, State University of New York, Upstate Medical University, Syracuse, 13202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2009.0124DOI Listing
January 2010
21 Reads
9 Citations
2.330 Impact Factor

Methyldopa-induced autoimmune haemolytic anaemia revisited.

N Z Med J 2009 Aug 21;122(1301):53-6. Epub 2009 Aug 21.

Department of Medicine, SUNY Upstate Medical University, Syracuse, NY-13202, USA.

View Article

Download full-text PDF

Source
August 2009
8 Reads
1 Citation

Colonic necrosis due to oral kayexalate in a critically-ill patient.

Am J Med Sci 2009 Apr;337(4):305-6

Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAJ.0b013e31818dd715DOI Listing
April 2009
14 Reads
3 Citations
1.515 Impact Factor

Expression of Nkx2.5 in wild type, cardiac mutant, and thyroxine-induced metamorphosed hearts of the Mexican axolotl.

Cardiovasc Toxicol 2009 Mar 4;9(1):13-20. Epub 2009 Feb 4.

Department of Medicine, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12012-009-9030-xDOI Listing
March 2009
11 Reads
5 Citations
2.060 Impact Factor

Pulmonary lymphangitic carcinomatosis as a primary manifestation of colon cancer in a young adult.

CMAJ 2008 Aug;179(4):338-40

Department of Medicine, State University of New York, Syracuse, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.080142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2492966PMC
August 2008
39 Reads
8 Citations
5.960 Impact Factor

Top co-authors

Giuseppe Giaccone
Giuseppe Giaccone

Lombardi Comprehensive Cancer Center

12
Arun Rajan
Arun Rajan

National Cancer Institute

10
Raffit Hassan
Raffit Hassan

National Cancer Institute

6
Sean Khozin
Sean Khozin

Center for Drug Evaluation and Research

5
Eva Szabo
Eva Szabo

National Cancer Institute

5
Bernard J Poiesz
Bernard J Poiesz

Upstate Medical University

5
Syamalima Dube
Syamalima Dube

SUNY Upstate Medical University

4
Seth M Steinberg
Seth M Steinberg

Center for Cancer Research

4
Dipak K Dube
Dipak K Dube

SUNY Upstate Medical University

3